CSTL Stock-Based Compensation
Castle Biosciences Inc · Stock-Based Compensation
CSTL Stock-Based Compensation
Latest reported$44.87Mperiod ending
CSTL TTM Stock-Based Comp ($293.64K → $44.87M)
TTM stock-based compensation
High-resolution chart · PNG
CSTL stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 44,871,000 | |
| 44,490,000 | |
| 45,893,000 | |
| 45,926,000 | |
| 46,853,000 | |
| 48,824,000 | |
| 50,320,000 | |
| 50,683,000 | |
| 50,699,000 | |
| 50,369,000 | |
| 51,219,000 | |
| 49,340,000 | |
| 45,493,000 | |
| 41,427,000 | |
| 36,321,000 | |
| 33,249,000 | |
| 29,263,000 | |
| 25,246,000 | |
| 21,740,000 | |
| 17,850,000 | |
| 14,758,000 | |
| 11,645,000 | |
| 8,309,000 | |
| 5,348,000 | |
| 3,459,484 | |
| 1,945,292 | |
| 536,713 | |
| 609,620 | |
| 454,528 | |
| 400,353 | |
| 293,639 |